HUP1400102A2 - Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation - Google Patents

Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation

Info

Publication number
HUP1400102A2
HUP1400102A2 HU1400102A HUP1400102A HUP1400102A2 HU P1400102 A2 HUP1400102 A2 HU P1400102A2 HU 1400102 A HU1400102 A HU 1400102A HU P1400102 A HUP1400102 A HU P1400102A HU P1400102 A2 HUP1400102 A2 HU P1400102A2
Authority
HU
Hungary
Prior art keywords
cocrystals
zanamivir
nanostructured
esters
compositions
Prior art date
Application number
HU1400102A
Other languages
Hungarian (hu)
Inventor
Zsolt Oetvoes
Genoveva Filipcsei
Ferenc Darvas
Gyoergy Dorman
Gabor Heltovics
Original Assignee
Darholding Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darholding Kft filed Critical Darholding Kft
Priority to HU1400102A priority Critical patent/HUP1400102A2/en
Publication of HUP1400102A2 publication Critical patent/HUP1400102A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
HU1400102A 2014-02-25 2014-02-25 Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation HUP1400102A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU1400102A HUP1400102A2 (en) 2014-02-25 2014-02-25 Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1400102A HUP1400102A2 (en) 2014-02-25 2014-02-25 Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation

Publications (1)

Publication Number Publication Date
HUP1400102A2 true HUP1400102A2 (en) 2015-08-28

Family

ID=89991420

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1400102A HUP1400102A2 (en) 2014-02-25 2014-02-25 Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation

Country Status (1)

Country Link
HU (1) HUP1400102A2 (en)

Similar Documents

Publication Publication Date Title
HK1249506A1 (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containging them
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
GB201409471D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
EP3199161A4 (en) Pharmaceutical preparation
PT3223796T (en) Pharmaceutical compositions, preparation and uses thereof
GB201409485D0 (en) Pharmaceutical composition
IL290114A (en) Pharmaceutical composition, preparation and uses thereof
SG11201704143YA (en) Pharmaceutical composition, preparation and uses thereof
EP3141243A4 (en) Pharmaceutical composition
PL3313370T3 (en) Ophthalmologic pharmaceutical composition
LT3229843T (en) Pharmaceutical composition, preparation and uses thereof
ZA201502073B (en) Pharmaceutical composition
HUP1400104A2 (en) Compositions comprising indometacine, its pharmaceutically acceptable salts and cocrystals; and process for the preparation
HUE060710T2 (en) Pharmaceutical composition comprising aprepitant and method for the preparation thereof
EP3170512A4 (en) Pharmaceutical composition
SG11201608123VA (en) Pharmaceutical composition for external use
SG11201608806XA (en) Highly unsaturated multi-modal polyisoolefin composition and process for preparation thereof
IL237572A0 (en) Process and intermediates for the preparation of dasatinib
EP3210199A4 (en) Diaper monitor
HUE050881T2 (en) Pharmaceutical composition
EP3175851A4 (en) Use of butenylphthalide, usage method thereof and method for preparing same into pharmaceutical composition
HUP1400518A2 (en) Process for the preparation of tofacitinib
HUP1400102A2 (en) Compositions comprising nanostructured zanamivir, its pharmaceutically acceptable salts, esters, cocrystals and process for the preparation
SG10201504332VA (en) Pharmaceutical Composition

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: DARHOLDING KFT., HU

Free format text: FORMER OWNER(S): DRUGGABILITY TECHNOLOGY IP HOLDCO (JERSEY) LIMITED, JE

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished